Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.69 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.58 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 6/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.52 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.52 |
| ▸ | HRH1 | P35367 | 1/20 | 0.52 |
| ▸ | DRD3 | P35462 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2223770 | 1.00 | ACE2 (0.69) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL2226046 | 1.00 | ACE2 (0.69) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL29125000 | 0.98 | ACE2 (0.71) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL2223259 | 0.98 | ACE2 (0.71) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL5879053 | 0.96 | ACE2 (0.65) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL5879054 | 0.96 | ACE2 (0.65) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL29124991 | 0.96 | ACE2 (0.69) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL28089681 | 0.94 | ACE2 (0.62) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL5879041 | 0.94 | ACE2 (0.67) | ACE2GRIK1GRIK2CA2MAPK1 | |
| SCHEMBL29124944 | 0.94 | ACE2 (0.67) | ACE2GRIK1GRIK2CA2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8933131-B2 | Intermediates and surfactants useful in household cleaning and personal care compositions, and methods of making the same | THE PROCTER & GAMBLE COMPANY (US) | 2015-01-13 | — | — | US | disclosed |
| EP-2523652-A1 | INTERMEDIATES AND SURFACTANTS USEFUL IN HOUSEHOLD CLEANING AND PERSONAL CARE COMPOSITIONS, AND METHODS OF MAKING THE SAME | The Procter & Gamble Company (US) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011088089-A1 | INTERMEDIATES AND SURFACTANTS USEFUL IN HOUSEHOLD CLEANING AND PERSONAL CARE COMPOSITIONS, AND METHODS OF MAKING THE SAME | THE PROCTER & GAMBLE COMPANY (US) | 2011-07-21 | — | — | WO | disclosed |
| US-20110171155-A1 | Intermediates And Surfactants useful In Household Cleaning And Personal Care Compositions, And Methods Of Making The Same | THE PROCTER & GAMBLE COMPANY | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110171155-A1 | Intermediates And Surfactants useful In Household Cleaning And Personal Care Compositions, And Methods Of Making The Same | HACD2, DSG1, HACD3 | ACE2 4232/4885GRIK1 2632/4885GRIK2 2431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.